ArticleAmerican journal of cancer research2025
Predictive value of CT radiomics and inflammatory markers for pulmonary adenocarcinoma spread through air spaces.
Article in American journal of cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo evaluate the predictive value of combining CT radiomics features and inflammatory markers for the preoperative prediction of spread through air spaces (STAS) in pulmonary adenocarcinoma.
methodsIn this retrospective study, we analyzed data from 256 patients diagnosed with pulmonary adenocarcinoma between 2021 and 2023. Patients were categorized into two groups based on the presence (n = 115) or absence (n = 141) of STAS, as confirmed by histopathological examination. CT imaging data and routine blood test results, including inflammatory markers, were collected. A validation cohort of 233 patients was included for external validation. Statistical analyses, including univariate and multivariate logistic regression, were performed to identify independent predictors of STAS. Model performance was assessed using Receiver Operating Characteristic curve analysis.
resultsKey CT radiomics features, such as density, satellite lesions, irregular shape, spiculation, vascular convergence, and the vacuole sign, were significantly associated with STAS. Among inflammatory markers, a lower lymphocyte-to-monocyte ratio (LMR) and higher neutrophil-to-lymphocyte (NLR) and platelet-to-lymphocyte ratios (PLR) were predictive of STAS. The combined predictive model, integrating CT radiomics and inflammatory markers, demonstrated a high discriminatory ability, achieving an area under the curve of 0.915, which was externally validated with an AUC of 0.847.
conclusionsThe combination of CT radiomics and inflammatory markers provides an effective, non-invasive preoperative tool for predicting STAS in pulmonary adenocarcinoma, aiding in early prognostication and treatment planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.